Impact of Idarucizumab and Andexanet Alfa on DOAC Plasma Concentration and ClotPro(R) Clotting Time: An Ex Vivo Spiking Study in A Cohort of Trauma Patients

D Oberladstatter; CJ Schlimp; J Zipperle; MF Osuchowski; W Voelckel; O Grottke; H Schochl

doi:10.3390/jcm10163476

Impact of Idarucizumab and Andexanet Alfa on DOAC Plasma Concentration and ClotPro(R) Clotting Time: An Ex Vivo Spiking Study in A Cohort of Trauma Patients

D Oberladstatter, CJ Schlimp, J Zipperle, MF Osuchowski, W Voelckel, O Grottke, H Schochl

Research output: Contribution to journal › Original Article › peer-review

12 Citations (Web of Science)

Original language	English
Pages (from-to)	3476
Journal	Journal of Clinical Medicine
Volume	10
Issue number	16
DOIs	https://doi.org/10.3390/jcm10163476
Publication status	Published - 2021

Keywords

DIRECT ORAL ANTICOAGULANTS
LOWER MORTALITY
WARFARIN
REVERSAL
DABIGATRAN

Access to Document

10.3390/jcm10163476

Cite this

@article{020ad24538354250a72df7af78c00da5,

title = "Impact of Idarucizumab and Andexanet Alfa on DOAC Plasma Concentration and ClotPro(R) Clotting Time: An Ex Vivo Spiking Study in A Cohort of Trauma Patients",

keywords = "DIRECT ORAL ANTICOAGULANTS, LOWER MORTALITY, WARFARIN, REVERSAL, DABIGATRAN",

author = "D Oberladstatter and CJ Schlimp and J Zipperle and MF Osuchowski and W Voelckel and O Grottke and H Schochl",

note = "Lehr-KH: AUVA Trauma Centre Salzburg, Department of Anaesthesiology and Intensive Care Medicine, Academic Teaching Hospital of the Paracelsus Medical University, 5020 Salzburg, AustriaAUVA Trauma Centre Linz, Department of Anaesthesiology and Intensive Care Medicine, 4010 Linz, Austria",

year = "2021",

doi = "10.3390/jcm10163476",

language = "English",

volume = "10",

pages = "3476",

journal = "Journal of Clinical Medicine",

issn = "2077-0383",

publisher = "MDPI",

number = "16",

}

TY - JOUR

T1 - Impact of Idarucizumab and Andexanet Alfa on DOAC Plasma Concentration and ClotPro(R) Clotting Time: An Ex Vivo Spiking Study in A Cohort of Trauma Patients

AU - Oberladstatter, D

AU - Schlimp, CJ

AU - Zipperle, J

AU - Osuchowski, MF

AU - Voelckel, W

AU - Grottke, O

AU - Schochl, H

N1 - Lehr-KH: AUVA Trauma Centre Salzburg, Department of Anaesthesiology and Intensive Care Medicine, Academic Teaching Hospital of the Paracelsus Medical University, 5020 Salzburg, AustriaAUVA Trauma Centre Linz, Department of Anaesthesiology and Intensive Care Medicine, 4010 Linz, Austria

PY - 2021

Y1 - 2021

KW - DIRECT ORAL ANTICOAGULANTS

KW - LOWER MORTALITY

KW - WARFARIN

KW - REVERSAL

KW - DABIGATRAN

U2 - 10.3390/jcm10163476

DO - 10.3390/jcm10163476

M3 - Original Article

C2 - 34441771

SN - 2077-0383

VL - 10

SP - 3476

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

IS - 16

ER -